H. Lundbeck AS Ordinary Shares - Class B
HLUN B: XCSE (DNK)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
DKK 14.80 | Gkjbz | Knhwmhq |
Lundbeck Posts Strong Year-End Results; Shares Attractive for Investors With Higher Risk Tolerance
Lundbeck reported solid year-end results, highlighted by quarterly revenue of DKK 4.7 billion, and full-year revenue of DKK 18.25 billion, representing 12% growth year-over-year. Continued strong performance from Lundbeck’s strategic brands (Trintellix, Abilify Maintena, Rexulti, and Vyepti) accounted for DKK 12 billion of sales in 2022.